Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
< b > Conditions < /b > : Hormone-Resistant Prostate Cancer; Stage IV Prostate Adenocarcinoma < br/ > < b > Interventions < /b > : Drug: Cabazitaxel; Drug: Prednisone < br/ > < b > Sponsors < /b > : University of California, Davis; Sanofi < br/ > < b > Not yet recruiting < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Hormone Resistant Prostate Cancer | Hormones | Prednisone | Prostate Cancer | Research